Maryland State Retirement & Pension System’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $586K | Hold |
4,661
| – | – | 0.01% | 854 |
|
|
2025
Q1 | $516K | Sell |
4,661
-663
| -12% | -$73.3K | 0.01% | 896 |
|
|
2024
Q4 | $727K | Sell |
5,324
-372
| -7% | -$50.8K | 0.02% | 837 |
|
|
2024
Q3 | $656K | Sell |
5,696
-1,754
| -24% | -$202K | 0.01% | 905 |
|
|
2024
Q2 | $1.03M | Hold |
7,450
| – | – | 0.02% | 673 |
|
|
2024
Q1 | $992K | Hold |
7,450
| – | – | 0.02% | 671 |
|
|
2023
Q4 | $982K | Hold |
7,450
| – | – | 0.02% | 697 |
|
|
2023
Q3 | $838K | Hold |
7,450
| – | – | 0.02% | 702 |
|
|
2023
Q2 | $703K | Hold |
7,450
| – | – | 0.01% | 851 |
|
|
2023
Q1 | $754K | Hold |
7,450
| – | – | 0.02% | 769 |
|
|
2022
Q4 | $890K | Buy |
+7,450
| New | +$890K | 0.03% | 620 |
|
|
2022
Q3 | – | Sell |
-7,049
| Closed | -$687K | – | 920 |
|
|
2022
Q2 | $687K | Hold |
7,049
| – | – | 0.02% | 727 |
|
|
2022
Q1 | $661K | Hold |
7,049
| – | – | 0.02% | 847 |
|
|
2021
Q4 | $600K | Hold |
7,049
| – | – | 0.02% | 968 |
|
|
2021
Q3 | $672K | Hold |
7,049
| – | – | 0.02% | 881 |
|
|
2021
Q2 | $687K | Hold |
7,049
| – | – | 0.02% | 611 |
|
|
2021
Q1 | $686K | Buy |
+7,049
| New | +$686K | 0.02% | 607 |
|